Company Filing History:
Years Active: 2025
Title: The Innovations of John Botson
Introduction
John Botson is a notable inventor based in Anchorage, AK (US). He has made significant contributions to the field of medicine, particularly in the treatment of gout. His innovative approach has led to the development of a patent that addresses a critical need in patient care.
Latest Patents
John Botson holds a patent for "Reducing immunogenicity to pegloticase." This patent provides methods of treating gout in patients by administering a PEGylated uricase. Additionally, it outlines methods for co-administering a PEGylated uricase and methotrexate (MTX) to enhance treatment efficacy. The patent also includes strategies for reducing the immunogenicity of a PEGylated uricase and prolonging the urate-lowering effect through co-administration with MTX. He has 1 patent to his name.
Career Highlights
John Botson is currently employed at Horizon Therapeutics USA, Inc., where he continues to work on innovative solutions for patients suffering from gout. His expertise and dedication to research have positioned him as a valuable asset in the pharmaceutical industry.
Collaborations
Some of his notable coworkers include Jeffrey D. Kent and Brian Lamoreaux, who contribute to the collaborative efforts at Horizon Therapeutics.
Conclusion
John Botson's work exemplifies the impact of innovation in medicine, particularly in the treatment of gout. His patent reflects a commitment to improving patient outcomes through advanced therapeutic methods.